TNFRSF1B and acute respiratory distress syndrome: In opposition, TNFR2, the other receptor of TNF-α, reduced hyperinflammation in COVID-19 acute respiratory distress syndrome (ARDS) after administering umbilical cord-derived mesenchymal stem cells [30].